- Home
- RGC vs HPI Comparison
RGC vs HPI Comparison
Compare RGC & HPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGC
- HPI
- Stock Information
- Founded
- RGC 2014
- HPI 2002
- Country
- RGC Hong Kong
- HPI United States
- Employees
- RGC N/A
- HPI N/A
- Industry
- RGC Medicinal Chemicals and Botanical Products
- HPI Trusts Except Educational Religious and Charitable
- Sector
- RGC Health Care
- HPI Finance
- Exchange
- RGC Nasdaq
- HPI Nasdaq
- Market Cap
- RGC 377.5M
- HPI 425.1M
- IPO Year
- RGC 2021
- HPI N/A
- Fundamental
- Price
- RGC $718.00
- HPI $15.78
- Analyst Decision
- RGC
- HPI
- Analyst Count
- RGC 0
- HPI 0
- Target Price
- RGC N/A
- HPI N/A
- AVG Volume (30 Days)
- RGC 91.2K
- HPI 64.7K
- Earning Date
- RGC 06-20-2025
- HPI 01-01-0001
- Dividend Yield
- RGC N/A
- HPI 8.97%
- EPS Growth
- RGC N/A
- HPI N/A
- EPS
- RGC N/A
- HPI N/A
- Revenue
- RGC N/A
- HPI N/A
- Revenue This Year
- RGC N/A
- HPI N/A
- Revenue Next Year
- RGC N/A
- HPI N/A
- P/E Ratio
- RGC N/A
- HPI N/A
- Revenue Growth
- RGC N/A
- HPI N/A
- 52 Week Low
- RGC $3.03
- HPI $12.85
- 52 Week High
- RGC $950.00
- HPI $16.83
- Technical
- Relative Strength Index (RSI)
- RGC 67.80
- HPI 43.07
- Support Level
- RGC $476.79
- HPI $15.77
- Resistance Level
- RGC $560.00
- HPI $15.98
- Average True Range (ATR)
- RGC 134.54
- HPI 0.19
- MACD
- RGC 34.08
- HPI -0.04
- Stochastic Oscillator
- RGC 67.60
- HPI 18.75
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About HPI John Hancock Preferred Income Fund of Beneficial Interest
John Hancock Preferred Income Fund is a closed-end, diversified management investment company. Its primary investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve its investment objectives by investing in securities that may be undervalued relative to similar securities in the marketplace. The fund's principal investment strategies include investing a majority of its assets in preferred stocks and other preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, and short-term investments.